![](https://www2.sellhealth.com/42/provestra_b_1_4.gif)
FDA Greenlights Controversial ‘Little Pink Pill’ with Stringent Restrictions
![FDA approves controversial pink pill with restrictions](https://infoflow13.com/wp-content/uploads/2024/07/d845ffb0thumbnail-768x576.jpeg)
The Food and Drug Administration (FDA) has approved flibanserin, a drug aimed at increasing women’s sexual desire, under the brand name Addyi. This decision follows a prolonged lobbying campaign by the drug’s makers and comes with numerous restrictions to mitigate…